High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.

Offidani, Massimo

High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia. [electronic resource] - The hematology journal : the official journal of the European Haematology Association 2003 - 47-53 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study

1466-4860

10.1038/sj.thj.6200222 doi


Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Betamethasone--administration & dosage
Bone Marrow Diseases--chemically induced
Burkitt Lymphoma--drug therapy
Comorbidity
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Disease-Free Survival
Drug Carriers
Female
Follow-Up Studies
Granulocyte Colony-Stimulating Factor--therapeutic use
Humans
Infections--etiology
Leukemia, T-Cell--drug therapy
Life Tables
Liposomes
Male
Methotrexate--administration & dosage
Middle Aged
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prospective Studies
Remission Induction
Safety
Survival Analysis
Topotecan--administration & dosage
Treatment Outcome